The Human Alpha-1 Proteinase Inhibitor Market in the US is expanding with increasing awareness and diagnosis of alpha-1 antitrypsin deficiency (AATD), a hereditary condition associated with progressive lung and liver complications. Human alpha-1 proteinase inhibitor therapies are used as augmentation treatment for eligible patients with severe AATD to help restore protective protein...